Drug
ST 01156
ST 01156: highest development phase Phase 1, developed by SEED Therapeutics, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- SEED Therapeutics, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| ST-01156 NCT07197554 | Phase 1 | Advanced Solid Tumors |
Latest
No recent events.
Follow ST 01156 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.